CONFERENCE COVERAGE 2015-03-31 Conference Coverage People with Parkinson’s disease have treatment options, but none directly tackle the underlying pathology of misfolded and aggregated α-synuclein. That may be poised to change, with numerous approaches targeting the protein now in the ...
JOB 2015-03-31 Employer University of Oslo Principal Investigator Lars Nilsson Contact Please submit your application electronically at http://uio.easycruit.com/. For questions on the positions, please contact Professor Lars Nilsson, email@example.com ...
CONFERENCE COVERAGE SERIES Biogen Antibody Buoyed by Phase 1 Data and Hungry Investors Antibody Against α-Synuclein Looks Safe In Early Trials The 12th AD/PD conference drew some 3,100 people from across the world to the Mediterranean city of Nice. After a long day of talks ...
PAPER Li W, West N, Colla E, Pletnikova O, Troncoso JC, Marsh L, Dawson TM, Jäkälä P, Hartmann T, Price DL, Lee MK
Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations.Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2162-7. Epub 2005 Jan 31 PubMed: 15684072
Center for Development of Advanced Medicine for DementiaObu
NonePhoenix, United States
The Jackson LaboratoryWest Hartford, United States
Indianapolis, United States
No filters selected